About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Ajanta Pharma Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
532331
ISIN Demat
INE031B01049
Book Value
289.81
NSE Code
AJANTPHARM
Dividend Yield %
1.04
Market Cap
335695.02
P/E
36.61
EPS
73.40
Face Value
2
BSE
NSE
04-Jul-2025
BSE
NSE
NSE F & O
04-Jul-2025
BSE
NSE
NSE F & O
Last Price
2687.45
Net Change
58
% Change
2.21%
Prev.Close
2629.45
Open
2651.00
High
2702.00
Low
2624.80
Volume
6291
Last Price
2695.50
Net Change
64
% Change
2.43%
Prev.Close
2631.50
Open
2645.00
High
2710.00
Low
2623.20
Volume
240560
Value
16824794
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
2702.00
52-Week High
3485.75
52-Week Low
2022.05
Value
643954122.8
Best Buy
2695.50
Best Sell
0.00
Best Quantity
510
Sell Quantity
0
Today's Range
2710.00
52-Week High
3485.00
52-Week Low
2160.15
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
510
Price
2695.50
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Bonus
1 : 2
22-Jun-22
Book Closure
23-Jul-20
30-Jul-20
Dividend
1400 %
06-Nov-24
Company News
19-06-2025
Ajanta Pharma informs abo...
17-06-2025
Ajanta Pharma informs ab...
12-05-2025
Ajanta Pharma informs abo...
05-05-2025
Ajanta Pharma informs abo...
02-05-2025
Ajanta Pharma informs abo...
21-03-2025
Ajanta Pharma to expand m...
20-03-2025
Ajanta Pharma informs abo...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
